腎性貧血治療の世界市場:販売動向2018

【英語タイトル】Global Renal Anemia Therapeutics Sales Market Report 2018

QYResearchが出版した調査資料(QYR80711089)・商品コード:QYR80711089
・発行会社(調査会社):QYResearch
・発行日:2018年10月
・ページ数:116
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、腎性貧血治療の世界市場について調査・分析し、腎性貧血治療のメーカー別販売量、市場シェア分析、種類別販売分析(DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、その他)、用途別販売分析(病院、研究センター、診療所)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、腎性貧血治療産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・腎性貧血治療市場概要
・腎性貧血治療のメーカー別販売量・メーカー別シェア
・腎性貧血治療の世界市場:種類別販売量(DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、その他)
・腎性貧血治療の世界市場:用途別販売量(病院、研究センター、診療所)
・腎性貧血治療の世界市場:地域別販売量・市場シェア
・腎性貧血治療の米国市場規模
・腎性貧血治療の中国市場規模
・腎性貧血治療の欧州市場規模
・腎性貧血治療の日本市場規模
・腎性貧血治療の東南アジア市場規模
・腎性貧血治療のインド市場規模
・腎性貧血治療のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・腎性貧血治療のコスト分析・価格動向
・腎性貧血治療の産業チェーン(サプライチェーン分析)
・腎性貧血治療のマーケティング戦略・販売チャネル、流通業者
・腎性貧血治療市場への影響要因分析
・腎性貧血治療の世界市場予測
・腎性貧血治療の米国市場予測
・腎性貧血治療の中国市場予測
・腎性貧血治療の欧州市場予測
・腎性貧血治療の日本市場予測
・腎性貧血治療の東南アジア市場予測
・腎性貧血治療のインド市場予測
・腎性貧血治療の種類別世界市場予測(DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、その他)
・腎性貧血治療の用途別世界市場予測(病院、研究センター、診療所)
...
【レポートの概要】

This report studies the global Renal Anemia Therapeutics market status and forecast, categorizes the global Renal Anemia Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).
The global Renal Anemia Therapeutics market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.

The major players covered in this report
Bayer AG
BIOCAD
CCM Duopharma Biotech Bhd.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy’s Laboratories Limited
Eli Lilly and Company
FibroGen, Inc.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Japan Tobacco Inc.
JCR Pharmaceuticals Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
DS-1093
EPO-018B
FG-2216
JTZ-951
MDGN-201
MMP-0101
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital
Research Center
Clinic

The study objectives of this report are:
To analyze and study the global Renal Anemia Therapeutics sales, value, status (2013-2017) and forecast (2018-2025);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Renal Anemia Therapeutics players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Renal Anemia Therapeutics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Renal Anemia Therapeutics Manufacturers
Renal Anemia Therapeutics Distributors/Traders/Wholesalers
Renal Anemia Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company’s specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Renal Anemia Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

【レポートの目次】

Table of Contents

Global Renal Anemia Therapeutics Sales Market Report 2018
1 Renal Anemia Therapeutics Market Overview
1.1 Product Overview and Scope of Renal Anemia Therapeutics
1.2 Classification of Renal Anemia Therapeutics by Product Category
1.2.1 Global Renal Anemia Therapeutics Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Renal Anemia Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 DS-1093
1.2.4 EPO-018B
1.2.5 FG-2216
1.2.6 JTZ-951
1.2.7 MDGN-201
1.2.8 MMP-0101
1.2.9 Others
1.3 Global Renal Anemia Therapeutics Market by Application/End Users
1.3.1 Global Renal Anemia Therapeutics Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 Hospital
1.3.2 Research Center
1.3.3 Clinic
1.4 Global Renal Anemia Therapeutics Market by Region
1.4.1 Global Renal Anemia Therapeutics Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.4.3 Europe Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.4.4 China Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.4.5 Japan Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.4.6 Southeast Asia Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.4.7 India Renal Anemia Therapeutics Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Renal Anemia Therapeutics (2013-2025)
1.5.1 Global Renal Anemia Therapeutics Sales and Growth Rate (2013-2025)
1.5.2 Global Renal Anemia Therapeutics Revenue and Growth Rate (2013-2025)

2 Global Renal Anemia Therapeutics Competition by Players/Suppliers, Type and Application
2.1 Global Renal Anemia Therapeutics Market Competition by Players/Suppliers
2.1.1 Global Renal Anemia Therapeutics Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Renal Anemia Therapeutics Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Renal Anemia Therapeutics (Volume and Value) by Type
2.2.1 Global Renal Anemia Therapeutics Sales and Market Share by Type (2013-2018)
2.2.2 Global Renal Anemia Therapeutics Revenue and Market Share by Type (2013-2018)
2.3 Global Renal Anemia Therapeutics (Volume and Value) by Region
2.3.1 Global Renal Anemia Therapeutics Sales and Market Share by Region (2013-2018)
2.3.2 Global Renal Anemia Therapeutics Revenue and Market Share by Region (2013-2018)
2.4 Global Renal Anemia Therapeutics (Volume) by Application

3 United States Renal Anemia Therapeutics (Volume, Value and Sales Price)
3.1 United States Renal Anemia Therapeutics Sales and Value (2013-2018)
3.1.1 United States Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
3.1.2 United States Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
3.1.3 United States Renal Anemia Therapeutics Sales Price Trend (2013-2018)
3.2 United States Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
3.3 United States Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
3.4 United States Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

4 Europe Renal Anemia Therapeutics (Volume, Value and Sales Price)
4.1 Europe Renal Anemia Therapeutics Sales and Value (2013-2018)
4.1.1 Europe Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
4.1.2 Europe Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
4.1.3 Europe Renal Anemia Therapeutics Sales Price Trend (2013-2018)
4.2 Europe Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

5 China Renal Anemia Therapeutics (Volume, Value and Sales Price)
5.1 China Renal Anemia Therapeutics Sales and Value (2013-2018)
5.1.1 China Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
5.1.2 China Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
5.1.3 China Renal Anemia Therapeutics Sales Price Trend (2013-2018)
5.2 China Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
5.3 China Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
5.4 China Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

6 Japan Renal Anemia Therapeutics (Volume, Value and Sales Price)
6.1 Japan Renal Anemia Therapeutics Sales and Value (2013-2018)
6.1.1 Japan Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
6.1.2 Japan Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
6.1.3 Japan Renal Anemia Therapeutics Sales Price Trend (2013-2018)
6.2 Japan Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Renal Anemia Therapeutics (Volume, Value and Sales Price)
7.1 Southeast Asia Renal Anemia Therapeutics Sales and Value (2013-2018)
7.1.1 Southeast Asia Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Renal Anemia Therapeutics Sales Price Trend (2013-2018)
7.2 Southeast Asia Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

8 India Renal Anemia Therapeutics (Volume, Value and Sales Price)
8.1 India Renal Anemia Therapeutics Sales and Value (2013-2018)
8.1.1 India Renal Anemia Therapeutics Sales and Growth Rate (2013-2018)
8.1.2 India Renal Anemia Therapeutics Revenue and Growth Rate (2013-2018)
8.1.3 India Renal Anemia Therapeutics Sales Price Trend (2013-2018)
8.2 India Renal Anemia Therapeutics Sales Volume and Market Share by Players (2013-2018)
8.3 India Renal Anemia Therapeutics Sales Volume and Market Share by Type (2013-2018)
8.4 India Renal Anemia Therapeutics Sales Volume and Market Share by Application (2013-2018)

9 Global Renal Anemia Therapeutics Players/Suppliers Profiles and Sales Data
9.1 Bayer AG
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bayer AG Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 BIOCAD
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 BIOCAD Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 CCM Duopharma Biotech Bhd.
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Chong Kun Dang Pharmaceutical Corp.
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Daiichi Sankyo Company, Limited
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Dong-A Socio Group
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Dong-A Socio Group Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Dr. Reddy’s Laboratories Limited
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Dr. Reddy’s Laboratories Limited Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Eli Lilly and Company
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Eli Lilly and Company Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 FibroGen, Inc.
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 FibroGen, Inc. Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 GlaxoSmithKline Plc
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Renal Anemia Therapeutics Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 GlaxoSmithKline Plc Renal Anemia Therapeutics Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 Intas Pharmaceuticals Ltd.
9.12 Japan Tobacco Inc.
9.13 JCR Pharmaceuticals Co., Ltd.
9.14 Jiangsu Hansoh Pharmaceutical Co., Ltd.

10 Renal Anemia Therapeutics Maufacturing Cost Analysis
10.1 Renal Anemia Therapeutics Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Renal Anemia Therapeutics
10.3 Manufacturing Process Analysis of Renal Anemia Therapeutics

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Renal Anemia Therapeutics Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Renal Anemia Therapeutics Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Renal Anemia Therapeutics Market Forecast (2018-2025)
14.1 Global Renal Anemia Therapeutics Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Renal Anemia Therapeutics Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Renal Anemia Therapeutics Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Renal Anemia Therapeutics Price and Trend Forecast (2018-2025)
14.2 Global Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Renal Anemia Therapeutics Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Renal Anemia Therapeutics Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 Europe Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 China Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Renal Anemia Therapeutics Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Renal Anemia Therapeutics Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Renal Anemia Therapeutics Sales Forecast by Type (2018-2025)
14.3.2 Global Renal Anemia Therapeutics Revenue Forecast by Type (2018-2025)
14.3.3 Global Renal Anemia Therapeutics Price Forecast by Type (2018-2025)
14.4 Global Renal Anemia Therapeutics Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Renal Anemia Therapeutics
Figure Global Renal Anemia Therapeutics Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Renal Anemia Therapeutics Sales Volume Market Share by Type (Product Category) in 2017
Figure DS-1093 Product Picture
Figure EPO-018B Product Picture
Figure FG-2216 Product Picture
Figure JTZ-951 Product Picture
Figure MDGN-201 Product Picture
Figure MMP-0101 Product Picture
Figure Others Product Picture
Figure Global Renal Anemia Therapeutics Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Renal Anemia Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Research Center Examples
Table Key Downstream Customer in Research Center
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Global Renal Anemia Therapeutics Market Size (Million USD) by Regions (2013-2025)
Figure United States Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Renal Anemia Therapeutics Sales Volume (K Pcs) (2013-2018)
Table Global Renal Anemia Therapeutics Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Renal Anemia Therapeutics Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Renal Anemia Therapeutics Sales Share by Players/Suppliers
Figure 2017 Renal Anemia Therapeutics Sales Share by Players/Suppliers
Figure Global Renal Anemia Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Renal Anemia Therapeutics Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Renal Anemia Therapeutics Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Renal Anemia Therapeutics Revenue Share by Players
Table 2017 Global Renal Anemia Therapeutics Revenue Share by Players
Table Global Renal Anemia Therapeutics Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Renal Anemia Therapeutics Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Renal Anemia Therapeutics by Type (2013-2018)
Figure Global Renal Anemia Therapeutics Sales Growth Rate by Type (2013-2018)
Table Global Renal Anemia Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Renal Anemia Therapeutics Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Renal Anemia Therapeutics by Type (2013-2018)
Figure Global Renal Anemia Therapeutics Revenue Growth Rate by Type (2013-2018)
Table Global Renal Anemia Therapeutics Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Renal Anemia Therapeutics Sales Share by Region (2013-2018)
Figure Sales Market Share of Renal Anemia Therapeutics by Region (2013-2018)
Figure Global Renal Anemia Therapeutics Sales Growth Rate by Region in 2017
Table Global Renal Anemia Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Renal Anemia Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Renal Anemia Therapeutics by Region (2013-2018)
Figure Global Renal Anemia Therapeutics Revenue Growth Rate by Region in 2017
Table Global Renal Anemia Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Renal Anemia Therapeutics Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Renal Anemia Therapeutics by Region (2013-2018)
Figure Global Renal Anemia Therapeutics Revenue Market Share by Region in 2017
Table Global Renal Anemia Therapeutics Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Renal Anemia Therapeutics Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Renal Anemia Therapeutics by Application (2013-2018)
Figure Global Renal Anemia Therapeutics Sales Market Share by Application (2013-2018)
Figure United States Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table United States Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure United States Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table United States Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table United States Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure United States Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table United States Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table United States Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure United States Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Figure Europe Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Europe Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table Europe Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Europe Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table Europe Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Europe Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Figure China Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table China Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table China Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure China Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table China Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table China Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure China Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table China Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table China Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure China Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Figure Japan Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Japan Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table Japan Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Japan Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table Japan Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Japan Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Figure Southeast Asia Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table Southeast Asia Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table Southeast Asia Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Figure India Renal Anemia Therapeutics Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Renal Anemia Therapeutics Sales Price (USD/Pcs) Trend (2013-2018)
Table India Renal Anemia Therapeutics Sales Volume (K Pcs) by Players (2013-2018)
Table India Renal Anemia Therapeutics Sales Volume Market Share by Players (2013-2018)
Figure India Renal Anemia Therapeutics Sales Volume Market Share by Players in 2017
Table India Renal Anemia Therapeutics Sales Volume (K Pcs) by Type (2013-2018)
Table India Renal Anemia Therapeutics Sales Volume Market Share by Type (2013-2018)
Figure India Renal Anemia Therapeutics Sales Volume Market Share by Type in 2017
Table India Renal Anemia Therapeutics Sales Volume (K Pcs) by Application (2013-2018)
Table India Renal Anemia Therapeutics Sales Volume Market Share by Application (2013-2018)
Figure India Renal Anemia Therapeutics Sales Volume Market Share by Application in 2017
Table Bayer AG Basic Information List
Table Bayer AG Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bayer AG Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Bayer AG Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure Bayer AG Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table BIOCAD Basic Information List
Table BIOCAD Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure BIOCAD Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure BIOCAD Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure BIOCAD Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table CCM Duopharma Biotech Bhd. Basic Information List
Table CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Sales Global Market Share (2013-2018
Figure CCM Duopharma Biotech Bhd. Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Chong Kun Dang Pharmaceutical Corp. Basic Information List
Table Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure Chong Kun Dang Pharmaceutical Corp. Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Daiichi Sankyo Company, Limited Basic Information List
Table Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure Daiichi Sankyo Company, Limited Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Dong-A Socio Group Basic Information List
Table Dong-A Socio Group Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dong-A Socio Group Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Dong-A Socio Group Renal Anemia Therapeutics Sales Global Market Share (2013-2018
Figure Dong-A Socio Group Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Dr. Reddy's Laboratories Limited Basic Information List
Table Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure Dr. Reddy's Laboratories Limited Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Renal Anemia Therapeutics Sales Global Market Share (2013-2018
Figure Eli Lilly and Company Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table FibroGen, Inc. Basic Information List
Table FibroGen, Inc. Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure FibroGen, Inc. Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure FibroGen, Inc. Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure FibroGen, Inc. Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Renal Anemia Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Renal Anemia Therapeutics Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Renal Anemia Therapeutics Sales Global Market Share (2013-2018)
Figure GlaxoSmithKline Plc Renal Anemia Therapeutics Revenue Global Market Share (2013-2018)
Table Intas Pharmaceuticals Ltd. Basic Information List
Table Japan Tobacco Inc. Basic Information List
Table JCR Pharmaceuticals Co., Ltd. Basic Information List
Table Jiangsu Hansoh Pharmaceutical Co., Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Renal Anemia Therapeutics
Figure Manufacturing Process Analysis of Renal Anemia Therapeutics
Figure Renal Anemia Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Renal Anemia Therapeutics Major Players in 2017
Table Major Buyers of Renal Anemia Therapeutics
Table Distributors/Traders List
Figure Global Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Renal Anemia Therapeutics Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Renal Anemia Therapeutics Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Renal Anemia Therapeutics Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Renal Anemia Therapeutics Sales Volume Market Share Forecast by Regions in 2025
Table Global Renal Anemia Therapeutics Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Renal Anemia Therapeutics Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Renal Anemia Therapeutics Revenue Market Share Forecast by Regions in 2025
Figure United States Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Renal Anemia Therapeutics Revenue and Growth Rate Forecast (2018-2025)
Figure China Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Renal Anemia Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Renal Anemia Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Renal Anemia Therapeutics Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Renal Anemia Therapeutics Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Renal Anemia Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Renal Anemia Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Renal Anemia Therapeutics Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Renal Anemia Therapeutics Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Renal Anemia Therapeutics Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

腎性貧血治療、DS-1093、EPO-018B、FG-2216、JTZ-951、MDGN-201、病院、研究センター、診療所

★調査レポート[腎性貧血治療の世界市場:販売動向2018] (コード:QYR80711089)販売に関する免責事項を必ずご確認ください。
★調査レポート[腎性貧血治療の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆